Countdown to 2021 CBIIC：
Senior analyst of Tianfeng Securities
ZHENG Wei graduated from the University of Science and Technology of China with the major of Biochemistry and Molecular Sciences, has completed several projects in the Guangzhou Institute of Biomedicine and Health over two years. After graduation, she worked for Mindray Biomedical Electronics Co., Ltd. (delisted from US stocks market, now waiting in line for China's stock market) in Shenzhen for five years. In the first two years, she focused on research and product development in the In Vitro Diagnostic Department, and then served as product marketing manager in the Strategic Development Department.In 2015 she left Mindray to Huatai Securities and worked as a senior researcher in medical group of Research Institute, responsible for the Medical Device plate. In 2016 she joined Tianfeng Securities as a senior researcher, responsible for the entire non-drug plate research work, including in vitro diagnosis, ultrasound, cardiovascular stent, blood purification and other fields. It is worth mentioning that she has a more in-depth study in the field of In Vitro Diagnosis, and completed a number of industry depth reports which were spread widely and were hit over 10,000 times.As the only brokerage analyst editorial board, she also participated in the compilation of industry association book of "2016 In Vitro Diagnosis blue book".